BTAI Competitors & Alternatives

Compare BioXcel Therapeutics Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

BTAI

Main Stock
$0.07
Tradestie Score
56
Market Cap
$50.49M
Revenue Growth
0.5%
Analyst Upside
+28993.4%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
CRON Cronos Group Inc. Common Share
$3.14
$1.02B 16.6 48 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$4.78
$711.32M - 40 Compare
ESPR Esperion Therapeutics, Inc.
$3.18
$584.71M - 53 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$57.08
$543.32M 152.3 43 Compare
EOLS Evolus, Inc. Common Stock
$7.84
$397.82M - 35 Compare
ALLO Allogene Therapeutics, Inc. Common Stock
$1.78
$275.13M - 46 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.08
$237.15M 5.2 53 Compare
ATRA Atara Biotherapeutics, Inc
$9.38
$101.48M - 32 Compare
KPTI Karyopharm Therapeutics Inc.
$1.61
$53.85M - 41 Compare
KYNB KYNB
$7.97
- - 44 Compare

Data updated: Sep 12, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry